UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Leslie Floren, PharmD, MA

Title(s)Academic Coordinator, Dean's Office
SchoolSchool of Pharmacy
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoPost-Doc Fellow/Scholar1997 School of Pharmacy
    University of California, San Francisco Residency School of Pharmacy
    University of California, San FranciscoPharm.D.1994 School of Pharmacy
    Collapse Awards and Honors
    2012UCSF Teaching Scholars Program
    2010Long Award for Excellence in Teaching
    2005  - 2012UCSF School of Pharmacy Dean’s Recognition for Excellence in Teaching
    1995  - 1997Postdoctoral Research Fellowship, Department of Biopharmaceutical Sciences, UCSF

    Collapse Overview 
    Collapse Overview
    Leslie Carstensen Floren, PharmD, DABCP is an Associate Adjunct Professor of Bioengineering and Therapeutic Sciences (BTS) in the School of Pharmacy at UCSF, the Academic Coordinator and Director of Professional and Postdoctoral Educational Affairs in BTS as well as the co-Director of the NIH-funded, UCSF Clinical Pharmacology Fellowship Training Program. Her teaching responsibilities for the past several years have included, primarily, teaching pharmacokinetics/pharmacodynamics, clinical pharmacology and principles of drug development and regulatory sciences to a wide variety of students, including professional students in the PharmD program, Clinical Pharmacology Fellows, junior faculty members, and working professionals from industrial backgrounds. Teaching is one of her greatest pleasures and she has been honored to receive the School of Pharmacy Dean’s Recognition for Excellence in Teaching every year since 2005 and, in 2010, she received the highest honor in the School of Pharmacy for teaching, the Long Award for Excellence in Teaching. Dr. Floren has a keen interest in curriculum development, teaching methodology and assessment, educational technology and online education and will begin training in the School of Medicine 2012-2013 Teaching Scholars Program in order to develop innovative curricula, to implement novel teaching methods and to use technology in order to “bring to life” the principles of Pharmacokinetics, Pharmacodynamics and Clinical Pharmacology for a wide variety of students within and across disciplines and, ultimately, to have a positive impact on patient health. She also plans to conduct scholarly research that will demonstrate the utility of practice-based teaching methods in order to advance interdisciplinary pharmaceutical sciences education within UCSF, our local community and across the country.

    Collapse Research 
    Collapse Research Activities and Funding
    General Clinical Research Center
    NIH/NCRR M01RR000079Dec 1, 1974 - Sep 29, 2006
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Floren LC, Mandal J, Dall'Era M, Shin J, Irby DM, Cate OT, O'Brien BC. A Mobile Learning Module to Support Interprofessional Knowledge Construction in the Health Professions. Am J Pharm Educ. 2020 Feb; 84(2):847519. PMID: 32226076.
      View in: PubMed
    2. Brouwer KLR, Schmidt S, Floren LC, Johnson JA. Clinical Pharmacology Education - The Decade Ahead. Clin Pharmacol Ther. 2020 Jan; 107(1):37-39. PMID: 31709518.
      View in: PubMed
    3. Floren LC, Donesky D, Whitaker E, Irby DM, Ten Cate O, O'Brien BC. Are We on the Same Page? Shared Mental Models to Support Clinical Teamwork Among Health Professions Learners: A Scoping Review. Acad Med. 2018 03; 93(3):498-509. PMID: 29028635.
      View in: PubMed
    4. Frassetto L, Floren L, Barin B, Browne M, Wolfe A, Roland M, Stock P, Carlson L, Christians U, Benet L. Changes in clearance, volume and bioavailability of immunosuppressants when given with HAART in HIV-1 infected liver and kidney transplant recipients. Biopharm Drug Dispos. 2013 Nov; 34(8):442-51. PMID: 24030928.
      View in: PubMed
    5. Daud AI, Xu C, Hwu WJ, Urbas P, Andrews S, Papadopoulos NE, Floren LC, Yver A, Deconti RC, Sondak VK.Cancer Chemother Pharmacol. Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon alpha-2b in patients with resected high-risk melanoma. 2011; (67):657-66.
    6. DeConti RC, Algazi AP, Andrews S, Urbas P, Born O, Stoeckigt D, Floren L, Hwang J, Weber J, Sondak VK, Daud AI.Br J Cancer. Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma. 2010; (10):1548-53.
    7. GR Tonn, SG Wong, SC Wong, MG Johnson, J Ma, R Cho, LC Floren, K Kersey, K Berry, AP Marcus, X Wang, B Van Lengerich, JC Medina, PG Pearson, and BK Wong.Drug Metab Dispos. An Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple Dosing. 2009; (37):502-13.
    8. A. P. Venook, E. K. Rowinsky, R. C. Donehower, T. Leung, L. C. Floren, M. Levy. Safety and pharmacokinetics (PK) of T138067 (T67) administered as a weekly 3-hour infusion in subjects with hepatocellular carcinoma (HCC) in a phase 1 study. Journal of Clinical Oncology. 2004 Jul 15; 22(14_suppl):4087-4087.
      View in: Publisher Site
    9. A. P. Venook, E. K. Rowinsky, R. C. Donehower, T. Leung, L. C. Floren, M. Levy. Safety and pharmacokinetics (PK) of T138067 (T67) administered as a weekly 3-hour infusion in subjects with hepatocellular carcinoma (HCC) in a phase 1 study. Journal of Clinical Oncology. 2004 Jul 15; 22(14_suppl):4087-4087.
      View in: Publisher Site
    10. LA Frassetto, Thai T, Aggarwal A, Bucher P, Jacobsen W, U Christians, LZ Benet, LC Floren.. Drug Metab Pharmacokinet. Pharmacokinetic Interactions between Cyclosporine and Protease Inhibitors in HIV+ Subjects. 2003; (18):114-20.
    11. LC Floren, A Wiznia , SA Hayashi, A Jaywardene, K Stanley, G Johnson, S Nachman, P Krosstad, F Aweeka.Pediatrics. Nelfinavir pharmacokinetics in stable HIV-positive children: AIDS Clinical Trials Group Protocol 377. 2003; 3(112):e220-27.
    12. L Mancinelli, L Frassetto, LC Floren, D Dressler, S Carrier, I Bekersky, LZ Benet, U Christians.Clin Pharmacol Ther. The pharmacokinetics and metabolic disposition of tacrolimus: a comparison across ethnic groups. 2001; (69):24-31.
    13. L.C. Floren, U. Christians, J.J. Zimmerman, L. Neefe, R. Schorer, D. Rushworth, D. Harper, J. Renz, L.Z. Benet. Sirolimus oral bioavailability increases ten-fold with concomitant ketoconazole. Clinical Pharmacology & Therapeutics. 1999 Feb 1; 65(2):159-159.
      View in: Publisher Site
    14. U Christians, W Jacobsen and LC Floren.. Pharmacol Ther. Metabolism and drug interactions of the 3-hydroxy-3methylglutaryl Coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar?. 1998; (80):1-34.
    15. LC Floren, MF Hebert, AP Venook, VC Jordan, A Cisneros, and KA Somberg.Ann Onc. Tamoxifen in liver disease: potential exacerbation of hepatic function. 1998; (9):1123-26.
    16. C Cheng and LC Floren.. CJHP. Pharmacogenetics: The clinical significance of cytochrome P450 polymorphisms. 1998; (10):11-4.
    17. LC Floren, I Bekersky, LZ Benet, QA Mekki, DE Dressler, JW Lee, JP Roberts, and MF Hebert.Clin Pharmacol Ther. Tacrolimus oral bioavailability doubles with co-administration of ketoconazole. 1997; (62):41-9.
    18. U Christians, LC Floren, G Kirchner, and K-F Sewing.Transplantationsmedizen. The clinical pharmacokinetics of macrolide immunosuppressants and its impact on the clinical management of organ transplantation. 1997; (9):S2-S6.
    19. L. Floren, J.G. Gambertoglio, S. Martin-Munley, F. Aweeka. Foscarnet Pharmacokinetics (PK) During Continuous Ambulatory Peritoneal Dialysis (CAPD). Clinical Pharmacology & Therapeutics. 1996 Feb 1; 59(2):142-142.
      View in: Publisher Site